BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Prasanna P, Kumar P, Kumar S, Rajana VK, Kant V, Prasad SR, Mohan U, Ravichandiran V, Mandal D. Current status of nanoscale drug delivery and the future of nano-vaccine development for leishmaniasis - A review. Biomed Pharmacother 2021;141:111920. [PMID: 34328115 DOI: 10.1016/j.biopha.2021.111920] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Wang D, Gu W, Chen W, Zhou J, Yu L, Kook Kim B, Zhang X, Seung Kim J. Advanced nanovaccines based on engineering nanomaterials for accurately enhanced cancer immunotherapy. Coordination Chemistry Reviews 2022;472:214788. [DOI: 10.1016/j.ccr.2022.214788] [Reference Citation Analysis]
2 Richter AR, Veras-neto JG, Sousa JS, Mendes JFS, Fontenelle ROS, Silva SANM, Marinho-filho JDB, Araújo AJ, Feitosa JPA, Paula HCB, Goycoolea FM, Paula RCMD. Effect of Acyl Chain Length on Hydrophobized Cashew Gum Self-Assembling Nanoparticles: Colloidal Properties and Amphotericin B Delivery. Colloids and Interfaces 2022;6:65. [DOI: 10.3390/colloids6040065] [Reference Citation Analysis]
3 Wasan E, Mandava T, Crespo-moran P, Nagy A, Wasan KM. Review of Novel Oral Amphotericin B Formulations for the Treatment of Parasitic Infections. Pharmaceutics 2022;14:2316. [DOI: 10.3390/pharmaceutics14112316] [Reference Citation Analysis]
4 Dalir Ghaffari A, Barati M, Ghaffarifar F, Pirestani M, Ebrahimi M, Karimipoursaryazdi A. Investigation of antileishmanial activities of CaO nanoparticles on L. tropica and L. infantum parasites, in vitro. J Parasit Dis 2022. [DOI: 10.1007/s12639-022-01539-6] [Reference Citation Analysis]
5 Mansur-Alves I, Lima BLF, Santos TT, Araújo NF, Frézard F, Islam A, de Barros AL, Dos Santos DC, Fernandes C, Ferreira LA, Aguiar MM. Cholesterol improves stability of amphotericin B nanoemulsion: promising use in the treatment of cutaneous leishmaniasis. Nanomedicine (Lond) 2022. [PMID: 36189757 DOI: 10.2217/nnm-2021-0489] [Reference Citation Analysis]
6 Prasad SR, Kumar P, Mandal S, Mohan A, Chaurasia R, Shrivastava A, Nikhil P, Aishwarya D, Ramalingam P, Gajbhiye R, Singh S, Dasgupta A, Chourasia M, Ravichandiran V, Das P, Mandal D. Mechanistic insight into the role of mevalonate kinase by a natural fatty acid-mediated killing of Leishmania donovani. Sci Rep 2022;12:16453. [PMID: 36180490 DOI: 10.1038/s41598-022-20509-9] [Reference Citation Analysis]
7 Scariot DB, Staneviciute A, Zhu J, Li X, Scott EA, Engman DM. Leishmaniasis and Chagas disease: Is there hope in nanotechnology to fight neglected tropical diseases? Front Cell Infect Microbiol 2022;12:1000972. [DOI: 10.3389/fcimb.2022.1000972] [Reference Citation Analysis]
8 Mazire PH, Saha B, Roy A. Immunotherapy for visceral leishmaniasis: A trapeze of balancing counteractive forces. Int Immunopharmacol 2022;110:108969. [PMID: 35738089 DOI: 10.1016/j.intimp.2022.108969] [Reference Citation Analysis]
9 Abbas M, Yan K, Li J, Zafar S, Hasnain Z, Aslam N, Iqbal N, Hussain SS, Usman M, Abbas M, Tahir M, Abbas S, Abbas SK, Qiulan H, Zhao X, El-Sappah AH. Agri-Nanotechnology and Tree Nanobionics: Augmentation in Crop Yield, Biosafety, and Biomass Accumulation. Front Bioeng Biotechnol 2022;10:853045. [PMID: 35557864 DOI: 10.3389/fbioe.2022.853045] [Reference Citation Analysis]
10 Varzandeh M, Mohammadinejad R, Esmaeilzadeh-Salestani K, Dehshahri A, Zarrabi A, Aghaei-Afshar A. Photodynamic therapy for leishmaniasis: Recent advances and future trends. Photodiagnosis Photodyn Ther 2021;36:102609. [PMID: 34728420 DOI: 10.1016/j.pdpdt.2021.102609] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]